Markets /GIKLY Grifols, S.A. GIKLY Add to watchlist Set alert Price alert · GIKLY Alert when the price is Price abovePrice below Price level Set alert All alert types 5.77 USD +0.22 +3.96% At close · Oct 30 5.77 Day range 5.77 5.06 52-week range 6.85 YTD -6.33%1 year -15.77% Open 5.77Prev close 5.55Mkt cap 7.85BVol 4Avg vol 45EPS 0.38P/E 15.18 More statistics Low 5.77High 5.77Earnings Nov 10, 2026 MAX chart 1D5D1M3M6MYTD1Y2Y5YMAX Chart tools Interval 1m5m15m30m Chart is warming up The all-time price history for GIKLY has not been loaded yet. Try again in a moment. OverviewEarningsFinancialsAnalystsDiscussionNewsOwnershipTrend ScoreAlertsOptions FinancialsValuation & health OverviewIncome statementBalance sheetCash flow Revenue & Expenses AnnualQuarterly Revenue by Segment FY 2025FY 2024FY 2023FY 2022 Haemoderivatives → Revenue: $6.49BRevenue → Gross Profit: $2.86BGross Profit → Net Income: $386.03MGross Profit → Selling, General & Admin: $1.06BGross Profit → Research & Development: $409.20MRevenue → Cost of Revenue: $4.67BGross Profit → Other Operating Expenses: $135.80MGross Profit → Interest Expense: $600.33MGross Profit → Other Expenses: $154.18MGross Profit → Income Tax: $110.46MTransfusional medicine → Revenue: $623.00MOther Product → Revenue: $243.00MBio supplies → Revenue: $154.00MOther diagnostic → Revenue: $17.00MGross Profit$2.86BCost of Revenue$4.67BNet Income$386.03MSelling, General & Admin$1.06BResearch & Development$409.20MOther Operating Expenses$135.80MInterest Expense$600.33MOther Expenses$154.18MIncome Tax$110.46MRevenue$7.52BHaemoderivatives$6.49BTransfusional medicine$623.00MOther Product$243.00MBio supplies$154.00MOther diagnostic$17.00M No annual statement lines GIKLY has no annual lines for this statement.
